ScreenerHero

RVPH Reviva Pharmaceuticals Holdings, Inc.

NAS · US · Healthcare · Biotechnology · revivapharma.com
0.4800USD-2.04%Mkt Cap: 6.29M $P/E: —

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap6.29M USD
Enterprise Value-13.05M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.86M USD
Revenue/Share—
Last Price0.4800 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.60
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.44
EPS (TTM)-1.44
EPS (Forward)-0.85
52W Range
0.26201% of range17.20
52W High17.20 USD
52W Low0.2620 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-229.71%
ROA-124.75%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.59M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-217.54%
Net Debt-19.75M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio3.56
Quick Ratio3.35
Book Value/Sh1.16 USD
Cash/Share1.52 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateMar 9, 2026
Analyst Consensus
Rating—
Target (Mean)17.50 USD
Upside (mean)+3545.8%
Target Range5.000 USD – 30.00 USD
5.000+3545.8% to mean30.00
# Analysts2
Ownership
Shares Out.13.11M
Float11.86M
Insiders7.73%
Institutions8.24%
Short Interest
Short Ratio3.4d
Short % Float14.95%
Short % Out.14.57%
Shares Short1.87M
Short (prev mo.)1.83M
Technical
SMA 500.4894 (-1.9%)
SMA 2001.907 (-74.8%)
Beta0.48
S&P 52W Chg16.45%
Avg Vol (30d)14.73K
Avg Vol (10d)23.82K
Technical Indicators
RSI (14)45.9
MACD0.0012
MACD Signal0.0029
MACD Hist.-0.0018
BB Upper0.5658 USD
BB Middle0.5054 USD
BB Lower0.4450 USD
BB Width23.90%
ATR (14)0.0594 USD
Vol Ratio (20d)0.72x